| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 2,339,649 | 2,354,550 | 1,571,773 | | Cost of Revenue | 1,306,022 | 1,333,253 | 1,017,641 | | | Gross Profit | 1,033,627 | 1,021,297 | 554,132 | | | Operating Expenses | | Research Development | 4,090 | 3,679 | 2,301 | | Selling General and Administrative | 148,455 | 150,081 | 148,958 | | Non Recurring | 85,214 | 109,545 | (45,769) | | Others | 240,020 | 229,914 | 171,333 | | | | Total Operating Expenses | 477,779 | 493,219 | 276,823 | | | | Operating Income or Loss | 555,848 | 528,078 | 277,309 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (258,435) | 20,392 | 49,697 | | Earnings Before Interest And Taxes | 408,364 | 518,543 | 297,635 | | Interest Expense | 11,572 | 43,572 | 37,090 | | Income Before Tax | 396,791 | 474,971 | 260,545 | | Income Tax Expense | (57,058) | 57,828 | (46,839) | | Minority Interest | (53,991) | 2,413 | (29,371) | | | | Net Income From Continuing Ops | 280,966 | 442,919 | 307,384 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 280,966 | 442,919 | 307,384 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $280,966 | $442,919 | $307,384 |
|
0.29% Nasdaq 
Income Statement
